Brandywine Oak Private Wealth LLC Synthetic Biologics, Inc. Transaction History

Brandywine Oak Private Wealth LLC

  • $959 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 09, 2019
SELL
$5.9 - $8.1 $94 - $129
-16 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$5.2 - $26.8 $83 - $428
16 New
16 $0

About Synthetic Biologics, Inc.

SYN Quotes by TradingView
  • Ticker SYN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,844,100
  • Market Cap $9.51M
  • Description
  • Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...
More about SYN
Track This Portfolio

Track Brandywine Oak Private Wealth LLC Portfolio

Follow Brandywine Oak Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Oak Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Oak Private Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email